Back to
Virtu Financial LLC
SCNI3 quarters
Position history for
Virtu Financial LLC's holdings in BIONDVAX PHARMACEUTICALS LTD
Yes. Virtu Financial holds 19,485 shares of SCNI (Biondvax Pharmaceuticals), worth $5,000, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$5,000
Current Shares
19,485
Total Value Change
-$6,000
Total Shares Change
+4,076
Quarter-by-Quarter History
Other major holders of SCNI: UBS Group AG, CITADEL ADVISORS LLC